[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1213182A1 - Pharmaceutical composition for external application - Google Patents

Pharmaceutical composition for external application

Info

Publication number
HK1213182A1
HK1213182A1 HK16101140.9A HK16101140A HK1213182A1 HK 1213182 A1 HK1213182 A1 HK 1213182A1 HK 16101140 A HK16101140 A HK 16101140A HK 1213182 A1 HK1213182 A1 HK 1213182A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
external application
external
application
pharmaceutical
Prior art date
Application number
HK16101140.9A
Other languages
Chinese (zh)
Inventor
阿度和克
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of HK1213182A1 publication Critical patent/HK1213182A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK16101140.9A 2013-03-29 2016-02-01 Pharmaceutical composition for external application HK1213182A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013072157 2013-03-29
PCT/JP2014/058716 WO2014157436A1 (en) 2013-03-29 2014-03-27 Pharmaceutical composition for external application

Publications (1)

Publication Number Publication Date
HK1213182A1 true HK1213182A1 (en) 2016-06-30

Family

ID=51624398

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101140.9A HK1213182A1 (en) 2013-03-29 2016-02-01 Pharmaceutical composition for external application

Country Status (5)

Country Link
JP (2) JP6738120B2 (en)
CN (1) CN105246471A (en)
HK (1) HK1213182A1 (en)
TW (1) TWI671069B (en)
WO (1) WO2014157436A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6599083B2 (en) * 2014-03-30 2019-10-30 小林製薬株式会社 Pharmaceutical composition for external use
JP6580306B2 (en) * 2014-03-30 2019-09-25 小林製薬株式会社 Pharmaceutical composition for external use
JP6580305B2 (en) * 2014-03-30 2019-09-25 小林製薬株式会社 Pharmaceutical composition for external use
JP6959594B2 (en) * 2014-11-12 2021-11-02 三笠製薬株式会社 Anti-inflammatory topical agent
JP6535853B2 (en) * 2014-11-12 2019-07-03 三笠製薬株式会社 Anti-inflammatory external preparation
US11090265B2 (en) 2015-01-30 2021-08-17 Medrx Co., Ltd. Aqueous preparation for external use
JP6817733B2 (en) * 2016-07-07 2021-01-20 小林製薬株式会社 Preparation for internal bleeding treatment
CN110114061A (en) * 2016-12-28 2019-08-09 小林制药株式会社 Topical composition
WO2018230687A1 (en) * 2017-06-16 2018-12-20 株式会社 メドレックス Anti-inflammatory and analgesic drug for external use
JP2022096997A (en) * 2020-12-18 2022-06-30 小林製薬株式会社 Pharmaceutical composition for external use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0780772B2 (en) * 1989-03-07 1995-08-30 積水化学工業株式会社 Transdermal formulation
JP3280711B2 (en) * 1992-08-26 2002-05-13 積水化学工業株式会社 Transdermal formulation
JPH07267862A (en) * 1994-03-29 1995-10-17 Sekisui Chem Co Ltd Transdermal plaster
JPH07285887A (en) * 1994-04-15 1995-10-31 Oishi Kouseidou:Kk Base for plaster
JP2006036687A (en) * 2004-07-27 2006-02-09 Nippon Zoki Pharmaceut Co Ltd Tramadol-containing medicinal composition for external use
JP5233149B2 (en) * 2007-03-31 2013-07-10 大正製薬株式会社 Adapalene-containing external preparation composition
CH699814B1 (en) * 2007-05-14 2010-05-14 Mepha Ag Diclofenac for topical application as a spray.
WO2009047785A2 (en) * 2007-06-08 2009-04-16 Patel Ketan R A non-aqueous topical solution of diclofenac and process for preparing the same
US20110294763A1 (en) * 2009-01-30 2011-12-01 Dordunoo Stephen K Transdermal delivery of dicolfenac, carbamazepine and benzydamine
JP2012193176A (en) * 2011-03-03 2012-10-11 Nippon Zoki Pharmaceut Co Ltd Milnacipran-containing pharmaceutical composition for percutaneous absorption
JP2014101338A (en) * 2012-11-22 2014-06-05 Japan Medic Kk Anti-inflammation and analgesic topical medicament

Also Published As

Publication number Publication date
JP2019034978A (en) 2019-03-07
TWI671069B (en) 2019-09-11
JP6738120B2 (en) 2020-08-12
JP2014208623A (en) 2014-11-06
WO2014157436A1 (en) 2014-10-02
JP6794420B2 (en) 2020-12-02
CN105246471A (en) 2016-01-13
TW201444553A (en) 2014-12-01

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical compositions
HUE046964T2 (en) Combined pharmaceutical composition
PL2943181T3 (en) Pharmaceutical compositions
GB201322602D0 (en) Pharmaceutical compounds
GB201306610D0 (en) Pharmaceutical compounds
PL3043778T3 (en) Pharmaceutical compositions containing refametinib
ZA201408333B (en) Pharmaceutical compositions
HK1213182A1 (en) Pharmaceutical composition for external application
EP2990038A4 (en) Solid pharmaceutical composition
IL244380A0 (en) Pharmaceutical compounds
SG11201601477VA (en) Pharmaceutical composition
GB201312386D0 (en) Pharmaceutical compounds
HUP1300496A2 (en) Stable pharmaceutical composition
HRP20171888T1 (en) Pharmaceutical compositions
HK1220143A1 (en) Pharmaceutical composition
EP2992890A4 (en) Pharmaceutical composition
GB201304699D0 (en) Pharmaceutical compositions
GB201304625D0 (en) New pharmaceutical composition
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
AU2013903813A0 (en) Pharmaceutical composition
GB201317166D0 (en) Pharmaceutical compounds
GB201316780D0 (en) Pharmaceutical compounds
GB201316791D0 (en) Pharmaceutical Compounds
GB201315733D0 (en) Pharmaceutical compounds